14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

ADMA Biologics Inc Stock Forecast

NASDAQ:ADMA BUY SELL

$2.07 (1.47%)

Volume: 1.442M

Closed: May 23, 2022

Hollow Logo Score: 4.865

ADMA Biologics Inc Stock Forecast

BUY SELL NASDAQ:ADMA
$2.07 (1.47%)

Volume: 1.442M

Closed: May 23, 2022

Score Hollow Logo 4.865

ADMA Biologics Inc Stock Forecast NASDAQ:ADMA

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2021-11-11 141.55% Raymond James $5.00 Upgrades Outperform Strong Buy
2021-11-09 117.39% Cantor Fitzgerald $4.50 Initiates Coverage On Overweight
2021-10-26 141.55% Raymond James $6.00 $5.00 Maintains Outperform
2021-08-12 189.86% HC Wainwright & Co. $7.00 $6.00 Maintains Buy
2021-07-06 238.16% HC Wainwright & Co. $10.00 $7.00 Maintains Buy
2021-03-26 189.86% Raymond James $7.00 $6.00 Maintains Outperform
2021-01-04 431.4% HC Wainwright & Co. $12.00 $11.00 Maintains Buy
2020-10-01 238.16% Raymond James $9.00 $7.00 Maintains Outperform
2020-05-07 238.16% Oppenheimer $14.00 $7.00 Maintains Outperform
2020-03-16 479.71% HC Wainwright & Co. $14.00 $12.00 Maintains Buy
2019-06-04 286.47% Jefferies $8.00 Initiates Coverage On Buy

ADMA Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 17.14% during the next 3 months and, with a 90% probability hold a price between $1.73 and $2.68 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $1.48 $1.89 $2.30
2022-05-26 $1.48 $1.89 $2.30
2022-05-27 $1.49 $1.90 $2.31
2022-05-31 $1.50 $1.90 $2.31
2022-06-01 $1.50 $1.91 $2.32
2022-06-02 $1.51 $1.92 $2.32
2022-06-03 $1.51 $1.92 $2.33
2022-06-06 $1.52 $1.93 $2.33
2022-06-07 $1.52 $1.93 $2.34
2022-06-08 $1.53 $1.94 $2.35
2022-06-09 $1.53 $1.94 $2.35
2022-06-10 $1.54 $1.95 $2.36
2022-06-13 $1.55 $1.95 $2.36
2022-06-14 $1.55 $1.96 $2.37
2022-06-15 $1.56 $1.96 $2.37
2022-06-16 $1.56 $1.97 $2.38
2022-06-17 $1.57 $1.98 $2.38
2022-06-21 $1.57 $1.98 $2.39
2022-06-22 $1.58 $1.99 $2.39
2022-06-23 $1.58 $1.99 $2.40
2022-06-24 $1.59 $2.00 $2.41
2022-06-27 $1.59 $2.00 $2.41
2022-06-28 $1.60 $2.01 $2.42
2022-06-29 $1.61 $2.01 $2.42
2022-06-30 $1.61 $2.02 $2.43
2022-07-01 $1.62 $2.02 $2.43
2022-07-05 $1.62 $2.03 $2.44
2022-07-06 $1.63 $2.04 $2.44
2022-07-07 $1.63 $2.04 $2.45
2022-07-08 $1.64 $2.05 $2.46

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT